Highlights
– Controversy surrounds long-term lipid lowering therapy
– SPIRIT IV and COMPARE trials show positive results
– Profile: Alfredo Galassi
[pdfviewer width=”100%” height=”940px” beta=”true”]http://cardiovascularnews.com/wp-content/uploads/sites/14/2016/06/16-Cardiovascular-News_for-Web.pdf[/pdfviewer]
